Sphera Funds Management’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.7M Buy
355,800
+85,800
+32% +$971K 0.52% 63
2026
Q2
$2.78M Buy
+270,000
New +$2.5M 0.36% 83

Other funds holding IMMX

Sphera Funds Management's IMMX Position: Q3 2026 in Review

Sphera Funds Management increased its Immix Biopharma (IMMX) stake by 32% in Q3 2026, buying an estimated $971K and bringing the position to 355,800 shares worth $3.7M. The position accounts for 0.52% of the portfolio, ranked #63.

Sphera Funds Management first reported a position in IMMX in Q2 2026 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Sphera Funds Management held 355,800 shares of Immix Biopharma worth $3.7M as of Q3 2026.
  • Sphera Funds Management bought 85,800 Immix Biopharma shares in Q3 2026, an estimated $971K.
  • Immix Biopharma made up 0.52% of Sphera Funds Management's portfolio in Q3 2026, its #63 holding.
  • Sphera Funds Management first reported a position in Immix Biopharma in Q2 2026 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Sphera Funds Management's 13F filing for Q3 2026, filed 16 Nov 2026.